Table 3.
Gene ontology analysis of potential target genes.
| Index | Pathway name | p value | Combined score |
|---|---|---|---|
| 1 | Breast cancer | 1.560e−10 | 977.53 |
| 2 | Estrogen signaling pathway | 0.00001 | 296.65 |
| 3 | Pathways in cancer | 0.00001 | 112.73 |
| 4 | Prolactin signaling pathway | 0.00006 | 378.56 |
| 5 | Signaling pathways regulating pluripotency of stem cells | 0.0004 | 150.80 |
| 6 | Gastric cancer | 0.0005 | 136.97 |
| 7 | Proteoglycans in cancer | 0.001 | 89.78 |
| 8 | Regulating of actin cytoskeleton | 0.001 | 82.04 |
| 9 | Endometrial cancer | 0.001 | 197.44 |
| 10 | Ras signaling pathway | 0.002 | 72.96 |
GO terms with P value ≤ 0.01 were considered as the significant level.